Sub-Total: $0.00
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Complimentary
Related products
-
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more -
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more -
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more -
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
